| 8 | 1/1 | 返回列表 |
| 查看: 2037 | 回復(fù): 7 | |||
| 【有獎(jiǎng)交流】積極回復(fù)本帖子,參與交流,就有機(jī)會(huì)分得作者 YT21 的 4 個(gè)金幣 ,回帖就立即獲得 1 個(gè)金幣,每人有 1 次機(jī)會(huì) | |||
[交流]
Hackensack Meridian School of Medicine(新澤西州)張毅實(shí)驗(yàn)室招聘三名博士后
|
|||
|
Three postdoctoral positions are available in Dr. Yi Zhang’s lab at Center for Discovery & Innovation, Hackensack Meridian School of Medicine (New Jersey). Dr. Zhang introduced for the first time the concept of alloantigen-sensitized stem cell memory T cells in sustaining alloimmunity. This concept of T cell stemness stimulates cancer immunotherapy field to develop novel strategies for improving the efficacy of cancer therapy. The Zhang lab has also discovered that Ezh2 plays multiple roles in the regulation of T cell stemness and T cell immunity. Currently, the Zhang lab studies epigenetic therapy, focusing on immune regulation and tumor immune-sensitization. Ongoing research projects investigate: 1) the molecular pathways that mediate Ezh2 actions in T cells; 2) epigenetic therapy to sensitize tumor to T cell immunity; and 3) novel genetic and pharmacologic approaches to program T cells for improving the efficacy of cancer immunotherapy. Advanced technologies, including drug-screening, CRISPR-editing and scRNA-sequencing analysis, are leveraged to facilitate these studies. The ideal candidate should have PhD degree or equivalent, with at least one 1st author publication. Background in immunology, cancer biology and molecular genetics is preferred. The candidate should be highly motivated and able to work independently under the PI’s supervision, with strong scientific ethnic. Please submit application electronically with CV, statement of interest and the names/ emails of three referees to: Dr. Yi Zhang (Professor), Email: yi.zhang@temple.edu. Hackensack Meridian School of Medicine(新澤西州)發(fā)現(xiàn)與創(chuàng)新中心的 Yi Zhang 博士實(shí)驗(yàn)室提供三個(gè)博士后職位。張博士首次創(chuàng)立了干細(xì)胞樣記憶T細(xì)胞維持同種異體抗原免疫反應(yīng)的概念。這一概念引導(dǎo)了癌癥免疫治療領(lǐng)域開(kāi)發(fā)提高癌癥治療功效的新策略。張實(shí)驗(yàn)室還發(fā)現(xiàn)Ezh2在調(diào)節(jié)T細(xì)胞干性和T細(xì)胞免疫中發(fā)揮多重作用。 目前,張實(shí)驗(yàn)室研究表觀遺傳療法,重點(diǎn)是免疫調(diào)節(jié)和腫瘤免疫致敏。正在進(jìn)行的項(xiàng)目研究:1) 在 T 細(xì)胞中介導(dǎo) Ezh2 作用的分子途徑; 2) 表觀遺傳療法增強(qiáng)腫瘤對(duì) T 細(xì)胞免疫敏感; 3) 新的遺傳和藥理學(xué)方法編程 T 細(xì)胞以提高癌癥免疫治療的功效。多項(xiàng)先進(jìn)的技術(shù),包括藥物篩選、CRISPR 編輯和 scRNA 測(cè)序分析,被用于促進(jìn)這些研究。 理想的候選人應(yīng)具有博士學(xué)位或同等學(xué)歷,至少有一篇第一作者發(fā)表。有免疫學(xué)、癌癥生物學(xué)和分子遺傳學(xué)背景者優(yōu)先。候選人應(yīng)具有高度的積極性,能夠在PI的指導(dǎo)下獨(dú)立工作,具有強(qiáng)烈的科學(xué)素養(yǎng)。請(qǐng)將申請(qǐng)電子版連同簡(jiǎn)歷、意向書(shū)和三位推薦人的姓名/電子郵件提交至:張毅博士,電子郵件:yi.zhang@temple.edu。 張毅教授的個(gè)人簡(jiǎn)介網(wǎng)址:https://medicine.temple.edu/yi-zhang (今年9月份正式搬去Hackensack Meridian School of Medicine,新實(shí)驗(yàn)室的網(wǎng)頁(yè)尚未準(zhǔn)備好) |
» 搶金幣啦!回帖就可以得到:
+2/170
+1/90
+1/82
+1/38
+1/27
+1/23
+2/19
+1/15
+1/7
+1/7
+1/7
+1/6
+3/6
+1/5
+1/5
+1/4
+1/3
+1/2
+1/1
+1/1
新蟲(chóng) (知名作家)
至尊木蟲(chóng) (文壇精英)
新蟲(chóng) (文壇精英)
| 8 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 化工專(zhuān)碩調(diào)劑 +4 | 利好利好. 2026-03-03 | 7/350 |
|
|---|---|---|---|---|
|
[考研] 理學(xué),工學(xué),農(nóng)學(xué)調(diào)劑,少走彎路,這里歡迎您! +8 | likeihood 2026-03-02 | 11/550 |
|
|
[考研] 266材料化工求調(diào)劑 +3 | 哇塞王帥 2026-03-03 | 3/150 |
|
|
[考研] 085602化學(xué)工程350,調(diào)劑,有沒(méi)有211的 +5 | 利好利好. 2026-03-02 | 9/450 |
|
|
[考研] 0805總分292,求調(diào)劑 +12 | 幻想之殤 2026-03-01 | 12/600 |
|
|
[考研] 環(huán)境調(diào)劑 +5 | 柒槿levana 2026-03-01 | 5/250 |
|
|
[考研]
材料270求調(diào)劑
6+6
|
Eiiiio 2026-03-01 | 11/550 |
|
|
[考研] 材料學(xué)碩318求調(diào)劑 +11 | February_Feb 2026-03-01 | 11/550 |
|
|
[考研] 材料類(lèi)考研調(diào)劑 +6 | gemmgemm 2026-03-01 | 7/350 |
|
|
[考研] 求調(diào)劑 +11 | yunziaaaaa 2026-03-01 | 13/650 |
|
|
[考研] 285求調(diào)劑 +9 | 滿(mǎn)頭大汗的學(xué)生 2026-02-28 | 9/450 |
|
|
[考研] 261求調(diào)劑 +3 | 陸lh 2026-03-01 | 3/150 |
|
|
[考研] 材料085601調(diào)劑 +5 | 多多子. 2026-03-02 | 5/250 |
|
|
[考研] 一志愿東北大學(xué)材料專(zhuān)碩328,求調(diào)劑 +3 | shs1083 2026-03-02 | 3/150 |
|
|
[基金申請(qǐng)] 此成果不能導(dǎo)入原因:元數(shù)據(jù)必填信息不完整,可 進(jìn)行補(bǔ)充。 +4 | Kittylucky 2026-03-02 | 5/250 |
|
|
[考研] 275求調(diào)劑 +3 | L-xin? 2026-03-01 | 6/300 |
|
|
[考研] 材料類(lèi)求調(diào)劑 +11 | wana_kiko 2026-02-28 | 14/700 |
|
|
[基金申請(qǐng)] 成果系統(tǒng)訪(fǎng)問(wèn)量大,請(qǐng)一小時(shí)后再?lài)L試。---NSFC啥時(shí)候好哦,已經(jīng)兩天這樣了 +4 | NSFC2026我來(lái)了 2026-02-28 | 4/200 |
|
|
[考研] 272求調(diào)劑 +6 | 田智友 2026-02-28 | 6/300 |
|
|
[考研] 311求調(diào)劑 +9 | 南迦720 2026-02-28 | 10/500 |
|